Works matching IS 09395555 AND DT 2023 AND VI 102 AND IP 9
Results: 40
Age-related differences in risks and outcomes of 30-day readmission in adults with sickle cell disease.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2329, doi. 10.1007/s00277-023-05365-5
- By:
- Publication type:
- Article
Insulin-like growth factor 1 receptor inhibits the proliferation of acute myeloid leukaemia cells via NK cell activation.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2353, doi. 10.1007/s00277-023-05378-0
- By:
- Publication type:
- Article
Secular trend in disease burden of leukemia and its subtypes in China from 1990 to 2019 and its projection in 25 years.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2375, doi. 10.1007/s00277-023-05372-6
- By:
- Publication type:
- Article
Antithrombotic secondary prophylaxis with low dose of apixaban or rivaroxaban in the onco-hematologic patients: comparison with non-neoplastic patients.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2599, doi. 10.1007/s00277-023-05369-1
- By:
- Publication type:
- Article
Platelet is an unfavorable prognostic biomarker and associated with leukemia stem cells and immunomodulatory factors in acute myeloid leukemia.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2365, doi. 10.1007/s00277-023-05367-3
- By:
- Publication type:
- Article
Are accessory spleen screening and resection in refractory immune cytopenia an effective strategy or a waste of resources?
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2309, doi. 10.1007/s00277-023-05360-w
- By:
- Publication type:
- Article
Correction to: Efficacy and safety of ixazomib plus lenalidomide and dexamethasone following injectable pi‑based therapy in relapsed/refractory multiple myeloma.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Improved survival of autologous stem cell transplantation in primary refractory and relapsed Hodgkin lymphoma in the brentuximab vedotin era — real-world data from Hungary.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2555, doi. 10.1007/s00277-023-05354-8
- By:
- Publication type:
- Article
Pretransplant spleen volume and outcome after hematopoietic stem cell transplantation (HSCT) in patients with acute myeloid leukemia (AML).
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2543, doi. 10.1007/s00277-023-05353-9
- By:
- Publication type:
- Article
The mTORC1 pathway participate in hyper-function of B cells in immune thrombocytopenia.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2317, doi. 10.1007/s00277-023-05348-6
- By:
- Publication type:
- Article
Meta-analysis of the results of haploidentical transplantation in the treatment of aplastic anemia.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2565, doi. 10.1007/s00277-023-05339-7
- By:
- Publication type:
- Article
Erythema nodosum as a manifestation of cytokine release syndrome after CAR T-cell therapy.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2641, doi. 10.1007/s00277-023-05338-8
- By:
- Publication type:
- Article
Molecular insights into hereditary elliptocytosis and pyropoikilocytosis: NGS uncovers multiple potential candidate genes.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2343, doi. 10.1007/s00277-023-05337-9
- By:
- Publication type:
- Article
Administration of tocilizumab in septic patients with pancytopenia and hyper-inflammatory syndrome.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2633, doi. 10.1007/s00277-023-05335-x
- By:
- Publication type:
- Article
Time-dependent analysis of the impact on early cytomegalovirus reactivation of HLA mismatch and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation from related donors in acquired aplastic anemia.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2589, doi. 10.1007/s00277-023-05332-0
- By:
- Publication type:
- Article
Cyclin D2-positive mantle cell lymphoma with t(2;12)(p12;p13) arising in immune deficiency/dysregulation.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2639, doi. 10.1007/s00277-023-05330-2
- By:
- Publication type:
- Article
Prognostic value of soluble programmed cell death ligand-1 (sPD-L1) in lymphoma: a systematic review and meta-analysis.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2425, doi. 10.1007/s00277-023-05325-z
- By:
- Publication type:
- Article
Paroxysmal nocturnal hemoglobinuria with ulcerative colitis.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2625, doi. 10.1007/s00277-023-05322-2
- By:
- Publication type:
- Article
Correction to: RE‑MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola‑BR), CAR‑T therapies, and lenalidomide/rituximab (R2) based on real‑world data in patients with relapsed/refractory diffuse large B‑cell lymphoma
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Risk factors and outcome of Stenotrophomonas maltophilia infection after allogeneic hematopoietic stem cell transplantation: JSTCT, Transplant Complications Working Group.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2507, doi. 10.1007/s00277-023-05320-4
- By:
- Publication type:
- Article
Characteristics and outcomes associated with venous thrombotic complications among patients with paroxysmal nocturnal hemoglobinuria.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2631, doi. 10.1007/s00277-023-05316-0
- By:
- Publication type:
- Article
COVID-19 infection outcomes in patients receiving CD20 targeting T-cell engaging bispecific antibodies for B-cell non-Hodgkin lymphoma.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2635, doi. 10.1007/s00277-023-05315-1
- By:
- Publication type:
- Article
The efficacy of first salvage therapy determines the outcomes of adult patients with type 1 primary refractory acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2627, doi. 10.1007/s00277-023-05313-3
- By:
- Publication type:
- Article
Allogeneic haematopoietic stem cell transplantation for myelofibrosis: prognostic indicators and the role of JAK2V617F measurable-residual disease monitoring by droplet-digital polymerase chain reaction.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2517, doi. 10.1007/s00277-023-05312-4
- By:
- Publication type:
- Article
Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2459, doi. 10.1007/s00277-023-05311-5
- By:
- Publication type:
- Article
Mast cell leukemia associated with essential thrombocythemia: a type of MCL-AHN (MCL-AMN).
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2621, doi. 10.1007/s00277-023-05310-6
- By:
- Publication type:
- Article
Trimethoprim-sulfamethoxazole prevents interstitial pneumonitis in B-cell lymphoma patients receiving chemotherapy: a propensity score matching analysis.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2387, doi. 10.1007/s00277-023-05303-5
- By:
- Publication type:
- Article
Heyde syndrome.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2617, doi. 10.1007/s00277-023-05299-y
- By:
- Publication type:
- Article
Comment on: JAK2 V617F-mutated polycythemia vera developing in a patient with a 20-year-long chronic myeloid leukemia at the time of first molecular response.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2619, doi. 10.1007/s00277-023-05297-0
- By:
- Publication type:
- Article
ADAR1 polymorphisms contribute to increased susceptibility in pediatric acute lymphoblastic leukemia.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2483, doi. 10.1007/s00277-023-05285-4
- By:
- Publication type:
- Article
The graft-versus-leukemia effect of prophylactic donor lymphocyte infusions after allogeneic stem cell transplantation is equally effective in relapse prevention but safer compared to spontaneous graft-versus-host disease.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2529, doi. 10.1007/s00277-023-05276-5
- By:
- Publication type:
- Article
Positron emission tomography to detect bone marrow involvement for patients with follicular lymphoma: a systematic review and meta-analysis.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2403, doi. 10.1007/s00277-023-05274-7
- By:
- Publication type:
- Article
Dynamic changes in circulating EBV-DNA load during treatment have prognostic values in EBV<sup>+</sup> DLBCL-NOS: a Chinese cohort study.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2471, doi. 10.1007/s00277-023-05260-z
- By:
- Publication type:
- Article
Clinical significance of plasma PD-L1<sup>+</sup> exosomes in the management of diffuse large B cell lymphoma.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2435, doi. 10.1007/s00277-023-05259-6
- By:
- Publication type:
- Article
Clinical features and prognosis of pediatric acute lymphocytic leukemia with JAK-STAT pathway genetic abnormalities: a case series.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2445, doi. 10.1007/s00277-023-05245-y
- By:
- Publication type:
- Article
Rapid molecular response to dasatinib in Ph-like acute lymphoblastic leukemia patients with ABL1 rearrangements: case series and literature review.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2397, doi. 10.1007/s00277-023-05236-z
- By:
- Publication type:
- Article
Tigecycline as salvage treatment of febrile neutropenia in patients with haematological malignancies—a retrospective single-centre analysis of 200 cases.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2607, doi. 10.1007/s00277-023-05222-5
- By:
- Publication type:
- Article
Efficacy and Safety of Ixazomib Plus Lenalidomide and Dexamethasone Following Injectable PI-Based Therapy in Relapsed/Refractory Multiple Myeloma.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2493, doi. 10.1007/s00277-023-05212-7
- By:
- Publication type:
- Article
MYC-targeted genes predict distant recurrence in patients with ocular adnexal extranodal marginal zone lymphoma.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2413, doi. 10.1007/s00277-023-05203-8
- By:
- Publication type:
- Article
Risk factors and prognosis of early death in secondary hemophagocytic lymphohistiocytosis.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2301, doi. 10.1007/s00277-023-05153-1
- By:
- Publication type:
- Article